Javier Martin

Summary

Publications

  1. doi Four-channel asymmetric Real-Time PCR hybridization probe assay: a rapid pre-screening method for critical BCR-ABL kinase domain mutations
    Jordi Martínez-Serra
    Department of Hematology, University Hospital of Son Espases, Carretera Valldemossa no 79, Palma de Mallorca, Spain
    Clin Biochem 45:345-51. 2012
  2. doi Rapid triplex asymmetric real-time PCR hybridization probe assay for the joint genotyping of F2, F5 and F12
    J Martínez-Serra
    Hospital Universitario de Son Dureta, Institut Universitari d Investigacions en Ciències de la Salut, Palma de Mallorca, Spain
    Clin Biochem 42:1317-24. 2009
  3. doi New real-time PCR-based method for the joint genotyping of JAK2 (V617F) with inherited thrombophilic F5 and F2 mutations
    J Martínez-Serra
    Servicio de Hematologia, Hospital Universitario de Son Dureta, Palma de Mallorca, C Andrea Doria, n degrees 55, 07014, Spain
    Clin Chim Acta 410:59-63. 2009
  4. doi Yondelis® (ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: new molecular insight into the mechanism of action
    Jordi Martínez-Serra
    Department of Hematology, University Hospital of Son Dureta, C Andrea Doria, n 55, Palma de Mallorca, Spain
    Eur J Pharmacol 658:57-64. 2011
  5. doi Inhibition of c-Myc down-regulation by sustained extracellular signal-regulated kinase activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small-cell lung cancer cells
    Jordi M Serra
    Department of Hematology, Institut Universitari d Investigacions en Ciències de la Salut, University Hospital Son Dureta, C Andrea Doria 55, E 07014 Palma de Mallorca, Spain
    Mol Pharmacol 73:1679-87. 2008

Collaborators

  • Simona Soverini
  • Regina Alemany
  • Jordi Martínez-Serra
  • J Martínez-Serra
  • Teresa Ros
  • Antonio Gutierrez
  • Juan Carlos Amat
  • Joan Besalduch
  • Teresa Bex
  • María Navarro-Palou
  • Jordi Gines
  • Carlos Saus
  • Oliver Vögler
  • A Gutierrez
  • J Besalduch
  • J C Amat
  • Jordi M Serra
  • Carmen Vidal
  • Sara Sanfelix
  • Josep Miquel Bauça
  • Carmen Santos
  • Toni F Marcús
  • Carmen Ballester
  • Andrés Novo
  • Joana M Plazas
  • Matias Diaz
  • Rafael Ramos
  • Elena Maffiotte
  • M Navarro
  • M A Duran
  • T Ros
  • A M Bautista
  • C Truyols
  • A Vila
  • H Lopez
  • M Canaro
  • B Galmes
  • E Maffiotte
  • M Julia
  • M Diaz
  • Maria Navarro
  • Antonia Sampol
  • Antonio Galmes
  • Lorenzo Serra-Moisés

Detail Information

Publications5

  1. doi Four-channel asymmetric Real-Time PCR hybridization probe assay: a rapid pre-screening method for critical BCR-ABL kinase domain mutations
    Jordi Martínez-Serra
    Department of Hematology, University Hospital of Son Espases, Carretera Valldemossa no 79, Palma de Mallorca, Spain
    Clin Biochem 45:345-51. 2012
    ..Since the incidence of patients with a mutation-related loss of response is not very high, it is very useful in the routine laboratory to perform a fast pre-screening method...
  2. doi Rapid triplex asymmetric real-time PCR hybridization probe assay for the joint genotyping of F2, F5 and F12
    J Martínez-Serra
    Hospital Universitario de Son Dureta, Institut Universitari d Investigacions en Ciències de la Salut, Palma de Mallorca, Spain
    Clin Biochem 42:1317-24. 2009
    ....
  3. doi New real-time PCR-based method for the joint genotyping of JAK2 (V617F) with inherited thrombophilic F5 and F2 mutations
    J Martínez-Serra
    Servicio de Hematologia, Hospital Universitario de Son Dureta, Palma de Mallorca, C Andrea Doria, n degrees 55, 07014, Spain
    Clin Chim Acta 410:59-63. 2009
    ..We decided to develop a new and rapid multiplex real-time Polymerase Chain Reaction (PCR) in order to detect the V617F mutation together with the inherited prothrombotic mutations of factors F5 and F2...
  4. doi Yondelis® (ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: new molecular insight into the mechanism of action
    Jordi Martínez-Serra
    Department of Hematology, University Hospital of Son Dureta, C Andrea Doria, n 55, Palma de Mallorca, Spain
    Eur J Pharmacol 658:57-64. 2011
    ..The study of this important mechanism of action should set up the basis for reassessing clinical therapy with Yondelis® in order to improve antitumor treatment outcome...
  5. doi Inhibition of c-Myc down-regulation by sustained extracellular signal-regulated kinase activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small-cell lung cancer cells
    Jordi M Serra
    Department of Hematology, Institut Universitari d Investigacions en Ciències de la Salut, University Hospital Son Dureta, C Andrea Doria 55, E 07014 Palma de Mallorca, Spain
    Mol Pharmacol 73:1679-87. 2008
    ....